CTContractTrader Dashboard Screener Sources Heatmap Companies Top Movers Trending Signals Alerts Watchlist Leaderboard Glossary Sign inRegister
Ticker / mid cap

BIO

Bio-Rad Laboratories, Inc.
2
Contracts
$23K
Total Value

Stock Metrics

6.8%
Short % Float
4.3d to cover · Moderate squeeze
91.2%
Inst % Float
10 holders · 2026-06-30
First Eagle Invest
Top Holder
12.0% of float
20.9M sh
Public Float
13/100
Dilution Score
Low
24+ mo
Cash Runway
Verified regulatory filings & proprietary analysis.

Fleet Intelligence

Dilution Risk
13/100
LOW
Inst: 91.25% · Top: First Eagle Investment Management, LLC
Biotech Analytics
F
Biotech / Pharma
4.74
Squeeze risk: MODERATEBiotech Grade: F

Biotech Analytics F Biotech / Pharma · score 4.74

Insider Buying0
Publications100
Dilution Risk13
Clinical Trials0
Short Interest30

Contracts

DateSourceTitleAwardeeValueScore
2026-05-07usaspending140G0126P0140BIO-RAD LABORATORIES, INC$13K0.0
2022-09-16usaspending75F40122P00174BIO-RAD LABORATORIES, INC$10K0.0

News Signals

Kyntra Bio, Inc. 2026 Q2 - Results - Earnings Call Presentationseeking_alpha 4d
BIO-key International, Inc. (BKYI) Q2 2026 Earnings Call Transcriptseeking_alpha 6d
Adicet Bio: A Cheap Gamma Delta T-Cell Playseeking_alpha 6d
Kyntra Bio, Inc. (KYNB) Q2 2026 Earnings Call Transcriptseeking_alpha 7d
Belite Bio, Inc (BLTE) Q2 2026 Earnings Call Transcriptseeking_alpha 7d
STAT+: Skylar Bio kicks off new gene therapy trial for deafnessstat_news 10d
TELA Bio, Inc. (TELA) Q2 2026 Earnings Call Transcriptseeking_alpha 10d
INmune Bio Inc. (INMB) Q2 2026 Earnings Call Transcriptseeking_alpha 14d